TNFSF13B and scleroderma: Using a scleroderma model, Matsushita et al. found that BAFF suppressed Bregs, while a BAFF antagonist reduced B effector cells but did not significantly alter Bregs (41), thus providing a molecular mechanism for a skewing toward Bregs in males.